Transactions

Katzenell Dimant / April 30, 2020

Our Firm Represented Capital Point Ltd. in the sale of a controlling stake in Nextgen Biomed Ltd. a company publicly traded on the Tel Aviv Stock Exchange – to a group of private investors

PREVIOUS     NEXT